Meiji Seika Is Latest To Kick Off Ustekinumab Phase III

Sees Positive Phase I Results For Stelara Biosimilar With Dong-A Socio Holdings

 
• By David Wallace
Starting blocks sprint race
Several companies are jostling for position on biosimilar Stelara • Source: Alamy

More from Biosimilars

More from Products